Suppr超能文献

重组变应原:现在与未来。

Recombinant allergens: the present and the future.

机构信息

Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Hum Vaccin Immunother. 2012 Oct;8(10):1534-43. doi: 10.4161/hv.22064. Epub 2012 Oct 1.

Abstract

Allergen specific immunotherapy (SIT) is the only known causative treatment of allergic diseases. Recombinant allergen-based vaccination strategies arose from a strong need to both to improve safety and enhance efficacy of SIT. In addition, new vaccines can be effective in allergies including food allergy or atopic dermatitis, which poorly respond to the current treatment with allergen extracts. A number of successful clinical studies with both wild-type and hypoallergenic derivatives of recombinant allergens vaccines have been reported for the last decade. They showed high efficacy and safety profile as well as very strong modulation of T and B cell responses to specific allergens.

摘要

变应原特异性免疫治疗(SIT)是唯一已知的治疗过敏性疾病的病因。基于重组变应原的疫苗接种策略的出现,既是为了提高安全性,也是为了增强 SIT 的疗效。此外,新型疫苗可有效治疗过敏症,包括食物过敏或特应性皮炎,这些过敏症对目前使用变应原提取物的治疗反应不佳。在过去十年中,已经有许多使用重组变应原疫苗的野生型和低变应原性衍生物的成功临床研究报告。它们显示出高效性和安全性,以及对特定变应原的 T 和 B 细胞反应的强烈调节作用。

相似文献

1
Recombinant allergens: the present and the future.
Hum Vaccin Immunother. 2012 Oct;8(10):1534-43. doi: 10.4161/hv.22064. Epub 2012 Oct 1.
2
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.
Vaccine. 2012 Jun 19;30(29):4328-35. doi: 10.1016/j.vaccine.2011.11.011. Epub 2011 Nov 17.
3
Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
Allergy. 2011 Jun;66(6):775-83. doi: 10.1111/j.1398-9995.2011.02565.x. Epub 2011 Feb 26.
5
Recombinant allergy vaccines based on allergen-derived B cell epitopes.
Immunol Lett. 2017 Sep;189:19-26. doi: 10.1016/j.imlet.2017.04.015. Epub 2017 May 1.
6
Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.
Int Arch Allergy Immunol. 2017;172(4):187-202. doi: 10.1159/000464104. Epub 2017 May 4.
7
Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
Immunol Allergy Clin North Am. 2006 May;26(2):179-89, v. doi: 10.1016/j.iac.2006.02.003.
8
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
J Intern Med. 2012 Aug;272(2):144-57. doi: 10.1111/j.1365-2796.2012.02556.x.
9
Strategies for converting allergens into hypoallergenic vaccine candidates.
Methods. 2004 Mar;32(3):313-20. doi: 10.1016/j.ymeth.2003.08.016.
10
Recombinant allergens: what does the future hold?
J Allergy Clin Immunol. 2011 Apr;127(4):860-4. doi: 10.1016/j.jaci.2011.02.016.

引用本文的文献

1
Enhancing production and assessing IgE reactivity of dog allergen Can f 6 in Pichia pastoris and Escherichia coli.
Appl Microbiol Biotechnol. 2025 Mar 29;109(1):78. doi: 10.1007/s00253-025-13465-7.
3
Selected Technical Aspects of Molecular Allergy Diagnostics.
Curr Issues Mol Biol. 2023 Jun 29;45(7):5481-5493. doi: 10.3390/cimb45070347.
4
Egg Allergy: Diagnosis and Immunotherapy.
Int J Mol Sci. 2020 Jul 16;21(14):5010. doi: 10.3390/ijms21145010.
6
Molecular allergy diagnostic tests: development and relevance in clinical practice.
Allergol Select. 2017 Aug 4;1(2):169-189. doi: 10.5414/ALX01617E. eCollection 2017.
8
Allergen Immunotherapy: Past, Present, and Future.
Allergy Asthma Immunol Res. 2016 May;8(3):191-7. doi: 10.4168/aair.2016.8.3.191.

本文引用的文献

1
Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.
Allergy. 2014 Sep;69(9):1162-70. doi: 10.1111/all.12461. Epub 2014 Jul 12.
2
IgE-binding epitopes: a reappraisal.
Allergy. 2011 Oct;66(10):1261-74. doi: 10.1111/j.1398-9995.2011.02656.x. Epub 2011 May 30.
3
Peptide and recombinant immunotherapy.
Immunol Allergy Clin North Am. 2011 May;31(2):377-89, xi. doi: 10.1016/j.iac.2011.03.008.
4
Immunotherapy with peptides.
Allergy. 2011 Jun;66(6):784-91. doi: 10.1111/j.1398-9995.2011.02610.x. Epub 2011 Apr 20.
5
Immunological mechanisms of allergen-specific immunotherapy.
Allergy. 2011 Jun;66(6):725-32. doi: 10.1111/j.1398-9995.2011.02589.x. Epub 2011 Apr 6.
6
Recombinant allergens: what does the future hold?
J Allergy Clin Immunol. 2011 Apr;127(4):860-4. doi: 10.1016/j.jaci.2011.02.016.
7
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.
J Allergy Clin Immunol. 2011 Jun;127(6):1562-70.e6. doi: 10.1016/j.jaci.2011.02.004. Epub 2011 Mar 16.
8
Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
Allergy. 2011 Jun;66(6):775-83. doi: 10.1111/j.1398-9995.2011.02565.x. Epub 2011 Feb 26.
9
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).
Allergy. 2011 Jun;66(6):713-24. doi: 10.1111/j.1398-9995.2010.02541.x. Epub 2011 Feb 15.
10
The advent of recombinant allergens and allergen cloning.
J Allergy Clin Immunol. 2011 Apr;127(4):855-9. doi: 10.1016/j.jaci.2010.12.1084. Epub 2011 Jan 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验